These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 35289966)

  • 21. pH-sensitive bromelain nanoparticles by ortho ester crosslinkage for enhanced doxorubicin penetration in solid tumor.
    Wang X; Xu J; Xu X; Fang Q; Tang R
    Mater Sci Eng C Mater Biol Appl; 2020 Aug; 113():111004. PubMed ID: 32487411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dual-targeting nanoparticles with core-crosslinked and pH/redox-bioresponsive properties for enhanced intracellular drug delivery.
    Zhao J; Yan C; Chen Z; Liu J; Song H; Wang W; Liu J; Yang N; Zhao Y; Chen L
    J Colloid Interface Sci; 2019 Mar; 540():66-77. PubMed ID: 30634060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor-targeting pH/redox dual-responsive nanosystem epigenetically reverses cancer drug resistance by co-delivering doxorubicin and GCN5 siRNA.
    Yuan Y; Liu J; Yu X; Liu X; Cheng Y; Zhou C; Li M; Shi L; Deng Y; Liu H; Wang G; Wang L; Wang Z
    Acta Biomater; 2021 Nov; 135():556-566. PubMed ID: 34496281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Programmed pH/reduction-responsive nanoparticles for efficient delivery of antitumor agents in vivo.
    Chen WL; Yang SD; Li F; Qu CX; Liu Y; Wang Y; Wang DD; Zhang XN
    Acta Biomater; 2018 Nov; 81():219-230. PubMed ID: 30267887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A tumor extracellular pH-sensitive PD-L1 binding peptide nanoparticle for chemo-immunotherapy of cancer.
    Zhu W; Bai Y; Zhang N; Yan J; Chen J; He Z; Sun Q; Pu Y; He B; Ye X
    J Mater Chem B; 2021 May; 9(20):4201-4210. PubMed ID: 33997867
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peptide dendrimer-Doxorubicin conjugate-based nanoparticles as an enzyme-responsive drug delivery system for cancer therapy.
    Zhang C; Pan D; Luo K; She W; Guo C; Yang Y; Gu Z
    Adv Healthc Mater; 2014 Aug; 3(8):1299-308. PubMed ID: 24706635
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stepwise dual pH and redox-responsive cross-linked polypeptide nanoparticles for enhanced cellular uptake and effective cancer therapy.
    Qu J; Wang R; Peng S; Shi M; Yang ST; Luo JB; Lin J; Zhou QH
    J Mater Chem B; 2019 Dec; 7(45):7129-7140. PubMed ID: 31663585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Small Morph Nanoparticles for Deep Tumor Penetration via Caveolae-Mediated Transcytosis.
    Zhang Z; Wang T; Yang R; Fu S; Guan L; Hou T; Mu W; Pang X; Liang S; Liu Y; Zhang N
    ACS Appl Mater Interfaces; 2020 Aug; 12(34):38499-38511. PubMed ID: 32805954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peptide-conjugated PAMAM for targeted doxorubicin delivery to transferrin receptor overexpressed tumors.
    Han L; Huang R; Liu S; Huang S; Jiang C
    Mol Pharm; 2010 Dec; 7(6):2156-65. PubMed ID: 20857964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduction Responsive Self-Assembled Nanoparticles Based on Disulfide-Linked Drug-Drug Conjugate with High Drug Loading and Antitumor Efficacy.
    Song Q; Wang X; Wang Y; Liang Y; Zhou Y; Song X; He B; Zhang H; Dai W; Wang X; Zhang Q
    Mol Pharm; 2016 Jan; 13(1):190-201. PubMed ID: 26629710
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microfluidics-Assisted Engineering of pH/Enzyme Dual-Activatable ZIF@Polymer Nanosystem for Co-Delivery of Proteins and Chemotherapeutics with Enhanced Deep-Tumor Penetration.
    Shen J; Ma M; Shafiq M; Yu H; Lan Z; Chen H
    Angew Chem Int Ed Engl; 2022 Mar; 61(14):e202113703. PubMed ID: 34989079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oleanolic acid-conjugated human serum albumin nanoparticles encapsulating doxorubicin as synergistic combination chemotherapy in oropharyngeal carcinoma and melanoma.
    Kumbham S; Paul M; Itoo A; Ghosh B; Biswas S
    Int J Pharm; 2022 Feb; 614():121479. PubMed ID: 35041911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amphiphilic peptide dendritic copolymer-doxorubicin nanoscale conjugate self-assembled to enzyme-responsive anti-cancer agent.
    Li N; Li N; Yi Q; Luo K; Guo C; Pan D; Gu Z
    Biomaterials; 2014 Nov; 35(35):9529-45. PubMed ID: 25145854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NIR-Light-Triggered Anticancer Strategy for Dual-Modality Imaging-Guided Combination Therapy via a Bioinspired Hybrid PLGA Nanoplatform.
    Shen X; Li T; Chen Z; Xie X; Zhang H; Feng Y; Li S; Qin X; Yang H; Wu C; Zheng C; Zhu J; You F; Liu Y
    Mol Pharm; 2019 Mar; 16(3):1367-1384. PubMed ID: 30776896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemotherapy Mediated by Biomimetic Polymeric Nanoparticles Potentiates Enhanced Tumor Immunotherapy via Amplification of Endoplasmic Reticulum Stress and Mitochondrial Dysfunction.
    Guo Y; Fan Y; Wang Z; Li G; Zhan M; Gong J; Majoral JP; Shi X; Shen M
    Adv Mater; 2022 Nov; 34(47):e2206861. PubMed ID: 36125843
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyaluronic acid ion-pairing nanoparticles for targeted tumor therapy.
    Li W; Yi X; Liu X; Zhang Z; Fu Y; Gong T
    J Control Release; 2016 Mar; 225():170-82. PubMed ID: 26826304
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Water-Responsive Hybrid Nanoparticles Codelivering ICG and DOX Effectively Treat Breast Cancer via Hyperthermia-aided DOX Functionality and Drug Penetration.
    Liu X; Wang C; Ma H; Yu F; Hu F; Yuan H
    Adv Healthc Mater; 2019 Apr; 8(8):e1801486. PubMed ID: 30856296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Doxorubicin-Bound Albumin Nanoparticles Containing a TRAIL Protein for Targeted Treatment of Colon Cancer.
    Thao le Q; Byeon HJ; Lee C; Lee S; Lee ES; Choi YW; Choi HG; Park ES; Lee KC; Youn YS
    Pharm Res; 2016 Mar; 33(3):615-26. PubMed ID: 26526555
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ultrasmall gold nanosatellite-bearing transformable hybrid nanoparticles for deep tumor penetration.
    Son S; Deepagan VG; Shin S; Ko H; Min J; Um W; Jeon J; Kwon S; Lee ES; Suh M; Lee DS; Park JH
    Acta Biomater; 2018 Oct; 79():294-305. PubMed ID: 30134209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism Investigation of Hyaluronidase-Combined Multistage Nanoparticles for Solid Tumor Penetration and Antitumor Effect.
    Chen E; Han S; Song B; Xu L; Yuan H; Liang M; Sun Y
    Int J Nanomedicine; 2020; 15():6311-6324. PubMed ID: 32922003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.